Other Events ·
Aptevo extends poison pill expiration to Oct 2027 and raises trigger price to $14.56
APVOAptevo Therapeutics Inc.
Aptevo Therapeutics Inc. entered into Amendment No. 6 to its Rights Agreement, extending the Final Expiration Date of its shareholder rights plan (poison pill) from October 23, 2026, to October 23, 2027. The amendment also modifies the Purchase Price for acquiring Preferred Shares to $14.56 per one-thousandth of a share. This adjustment maintains the company's defense against unsolicited acquisition attempts while updating the financial terms associated with the rights plan. Aptevo Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases.